Project Details
Description
Alport syndrome is a rare genetic disorder and the second most common form of inherited kidney disease. This is caused by the genes needed to create a type of collagen that plays a key role in kidney function.
Currently, there is no cure for Alport syndrome. The available treatments aim to slow the progression of kidney disease and to alleviate symptoms. There is a great need for more targeted and effective therapies to treat Alport syndrome.
The Alport Research Hub is funded by the Stoneygate Trust and Kidney Research UK, with Alport UK as a collaborator. The hub aims to transform early diagnosis and specific treatments for patients with Alport syndrome.
Currently, there is no cure for Alport syndrome. The available treatments aim to slow the progression of kidney disease and to alleviate symptoms. There is a great need for more targeted and effective therapies to treat Alport syndrome.
The Alport Research Hub is funded by the Stoneygate Trust and Kidney Research UK, with Alport UK as a collaborator. The hub aims to transform early diagnosis and specific treatments for patients with Alport syndrome.
Status | Active |
---|---|
Effective start/end date | 1/04/22 → 31/03/27 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.